<?xml version="1.0" encoding="UTF-8"?>
<p>Taken together, stem cell therapy, regarding its scaffold and paracrine effects can result in prevention of remodeling and HF improvement in ischemic heart cases. This has an important role in improving the symptoms and QoL of such patients [
 <xref rid="R26" ref-type="bibr">26</xref>]. Moreover, better patient follow-up and better and more precise control and regulation of drug therapy and daily regimen during the treatment course can have remarkable outcomes on improving adherence and satisfaction among patients.
</p>
